Concord Drugs Limited (BSE: 538965)
Health Care · Pharmaceuticals · IN
Rs70.40
-7.00% today · +5.9% 1Y
Concord Drugs Limited (BSE: 538965) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $9.58M.
Over the last twelve months the share price has gained 5.9%, trading between 61.00 and 92.52.
Tweenvest scores Concord Drugs Limited across four factors: quality 60/100, value 41/100, growth 12/100. Its strongest factor is quality.
538965 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.58M
- Revenue (TTM)
- $9.10M
- P/E
- 40.94
- EPS
- 1.72
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- Rs92.52
- 52-week low
- Rs61.00
- Avg volume (3M)
- —
- Shares outstanding
- 13.18M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Libra Infusions LimitedDSE: LIBRAINFU | $10.08M | Tk551.00 | -2.53% |
| Advent Pharma Ltd.DSE: ADVENT | $9.91M | Tk13.10 | -2.24% |
| Y.B Urban Renewal - Residential Development LtdTASE: YBRD | $9.70M | ₪6.15 | +8.43% |
| Rapid Dose Therapeutics Corp.CNSX: DOSE | $9.66M | CA$0.10 | -16.67% |
| Active Fine Chemicals LimitedDSE: ACTIVEFINE | $9.55M | Tk4.90 | -10.91% |
| Mercury Laboratories LimitedBSE: 538964 | $9.54M | Rs770.00 | +2.94% |
| S.C. Sintofarm S.A.BVB: SINT | $9.37M | RON— | — |
| Marinomed Biotech AGWBAG: MARI | $9.11M | €— | — |
Figures last refreshed Oct 11, 2026.